Page last updated: 2024-10-30

metformin and BCKD Deficiency

metformin has been researched along with BCKD Deficiency in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Tsai, HY1
Wu, SC1
Li, JC1
Chen, YM1
Chan, CC1
Chen, CH1
S Sonnet, D1
N O'Leary, M1
A Gutierrez, M1
M Nguyen, S1
Mateen, S1
Hsu, Y1
P Mitchell, K1
J Lopez, A1
Vockley, J1
K Kennedy, B1
Ramanathan, A1

Other Studies

2 other studies available for metformin and BCKD Deficiency

ArticleYear
Loss of the
    Disease models & mechanisms, 2020, 08-27, Volume: 13, Issue:8

    Topics: Amino Acids, Branched-Chain; Animals; Animals, Genetically Modified; Apoptosis; Brain; Casein Kinase

2020
Metformin inhibits Branched Chain Amino Acid (BCAA) derived ketoacidosis and promotes metabolic homeostasis in MSUD.
    Scientific reports, 2016, 07-04, Volume: 6

    Topics: Amino Acids, Branched-Chain; Animals; Chromatography, Liquid; Disease Models, Animal; Female; Fibrob

2016